المؤلفون: G. S. Nuralieva, A. E. Shmidt, I. S. Avdeev, G. V. Nekludova, Г. С. Нуралиева, А. Е. Шмидт, И. С. Авдеев, Г. В. Неклюдова

المصدر: Meditsinskiy sovet = Medical Council; Online First ; Медицинский Совет; Online First ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: курение, prolonged oxygen therapy, hypoxemia, arterial blood gas composition, smoking, длительная кислородотерапия, гипоксемия, газовый состав артериальной крови

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8667/7610; Авдеев СН. Длительная кислородотерапия при хронической дыхательной недостаточности. М.: ФГУ «НИИ Пульмонологии ФМБА» России; 2011. 22 с. Режим доступа: https://lim-nn.ru/upload/iblock/d6f/jffmmegifaqjzcwq%20hjnjypvk.pdf.; Hardinge M, Suntharalingam J, Wilkinson T. Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults. Thorax. 2015;70(6):589–591. https://doi.org/10.1136/thoraxjnl-2015-206918.; Jacobs SS, Krishnan JA, Lederer DJ, Ghazipura M, Hossain T, Tan AM et al. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(10):e121–e141. https://doi.org/10.1164/rccm.202009-3608ST.; Lin LY, Wu YC, Wu JS, Tai HY, Huang TW, Cheng WH. Oxygen therapy for exercise capacity in fibrotic interstitial lung disease: A systematic review and meta-analysis of randomised controlled trials. Respir Med. 2024;227:107657. https://doi.org/10.1016/j.rmed.2024.107657.; Bell EC, Cox NS, Goh N, Glaspole I, Westall GP, Watson A, Holland AE. Oxygen therapy for interstitial lung disease: a systematic review. Eur Respir Rev. 2017;26(143):160080. https://doi.org/10.1183/16000617.0080-2016.; Rantala HA, Leivo-Korpela S, Lehtimäki L, Lehto JT. Predictors of Impaired Survival in Subjects With Long-Term Oxygen Therapy. Respir Care. 2019;64(11):1401–1409. https://doi.org/10.4187/respcare.06615.; Ishiwari M, Kono Y, Togashi Y, Kobayashi K, Kikuchi R, Kogami M, Abe S. Prognostic significance of antifibrotic agents in idiopathic pulmonary fibrosis after initiation of long-term oxygen therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2024;41(1):e2024002. https://doi.org/10.36141/svdld.v41i1.15264.; Kataoka K, Oda K, Takizawa H, Ogura T, Miyamoto A, Inoue Y et al. Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy. Sci Rep. 2023;13(1):13664. https://doi.org/10.1038/s41598-023-40508-8.; Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. https://doi.org/10.1056/nejmoa021322.; Koczulla AR, Schneeberger T, Jarosch I, Kenn K, Gloeckl R. Long-Term Oxygen Therapy. Dtsch Arztebl Int. 2018;115(51-52):871–877. https://doi.org/10.3238/arztebl.2018.0871.; Lacasse Y, Thériault S, St-Pierre B, Bernard S, Sériès F, Bernatchez HJ, Maltais F. Oximetry neither to prescribe long-term oxygen therapy nor to screen for severe hypoxaemia. ERJ Open Res. 2021;7(4):00272–2021. https://doi.org/10.1183/23120541.00272-2021.; Fleetham JA, Bradley CA, Kryger MH, Anthonisen NR. The effect of low flow oxygen therapy on the chemical control of ventilation in patients with hypoxemic COPD. Am Rev Respir Dis. 1980;122(6):833–840. https://doi.org/10.1164/arrd.1980.122.6.833.; Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981;1(8222):681–686. Available at: https://pubmed.ncbi.nlm.nih.gov/6110912/.; Gulbas G, Gunen H, In E, Kilic T. Long-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatment. Int J Clin Pract. 2012;66(2):152–157. https://doi.org/10.1111/j.1742-1241.2011.02833.x.; Chiang LL, Hung TC, Ho SC, Lin HC, Yu CT, Wang CH, Kuo HP. Respiratory response to carbon dioxide stimulation during low flow supplemental oxygen therapy in chronic obstructive pulmonary disease. J Formos Med Assoc. 2002;101(9):607–615. Available at: https://pubmed.ncbi.nlm.nih.gov/12645187/.; Haldane JS. The therapeutic administration of oxygen. Br Med J. 1917;1(2928):181–183. https://doi.org/10.1136/bmj.1.2928.181.; Ameer F, Carson KV, Usmani ZA, Smith BJ. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database Syst Rev. 2014;2014(6):CD000238. https://doi.org/10.1002/14651858.cd000238.pub2.; Glezer S, Hess MW, Kamada AK. Patient Use Patterns of Portable Oxygen Concentrators. Pulm Ther. 2024;10(1):123–132. https://doi.org/10.1007/s41030-024-00252-4.; Neff TA, Petty TL. Long-term continuous oxygen therapy in chronic airway obstruction. Mortality in relationship to cor pulmonale, hypoxia, and hypercapnia. Ann Intern Med. 1970;72(5):621–626. https://doi.org/10.7326/0003-4819-72-5-621.; Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980;93(3):391–398. https://doi.org/10.7326/0003-4819-93-3-391.; Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987;42(2):105–110. https://doi.org/10.1136/thx.42.2.105.; Machado MC, Krishnan JA, Buist SA, Bilderback AL, Fazolo GP, Santarosa MG et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(5):524–549. https://doi.org/10.1164/rccm.200507-1057OC.; Annaka H, Nomura T, Moriyama H. Predictors of 2-Year Mortality in Patients Receiving Long-Term Oxygen Therapy: A Prospective Observational Study. J Palliat Med. 2024;27(4):495–502. https://doi.org/10.1089/jpm.2023.0505.; Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med. 2004;98(4):285–293. https://doi.org/10.1016/j.rmed.2003.10.008.; Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1983;143(10):1941–1947. Available at: https://pubmed.ncbi.nlm.nih.gov/6625781/.; Borak J, Sliwiński P, Tobiasz M, Górecka D, Zieliński J. Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch Chest Dis. 1996;51(1):7–11. Available at: https://pubmed.ncbi.nlm.nih.gov/8901313/.; MacNee W, Morgan AD, Wathen CG, Muir AL, Flenley DC. Right ventricular performance during exercise in chronic obstructive pulmonary disease. The effects of oxygen. Respiration. 1985;48(3):206–215. https://doi.org/10.1159/000194831.; Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med. 1985;102(1):29–36. https://doi.org/10.7326/0003-4819-102-1-29.; Zieliński J, Tobiasz M, Hawryłkiewicz I, Sliwiński P, Pałasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest. 1998;113(1):65–70. https://doi.org/10.1378/chest.113.1.65.; Roberts DH, Lepore JJ, Maroo A, Semigran MJ, Ginns LC. Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest. 2001;120(5):1547–1555. https://doi.org/10.1378/chest.120.5.1547.; Ulrich S, Keusch S, Hildenbrand FF, Lo Cascio C, Huber LC, Tanner FC et al. Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial. Eur Heart J. 2015;36(10):615–623. https://doi.org/10.1093/eurheartj/eht540.; Somfay A, Porszasz J, Lee SM, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J. 2001;18(1):77–84. https://doi.org/10.1183/09031936.01.00082201.; Jarosch I, Gloeckl R, Damm E, Schwedhelm AL, Buhrow D, Jerrentrup A et al. Short-term Effects of Supplemental Oxygen on 6-Min Walk Test Outcomes in Patients With COPD: A Randomized, Placebo-Controlled, Single-blind, Crossover Trial. Chest. 2017;151(4):795–803. https://doi.org/10.1016/j.chest.2016.11.044.; Björklund F, Palm A, Gorani JA, Ahmadi Z, Sundh J, Theorell-Haglöw J et al. Breathlessness and exercise performance to predict mortality in long-term oxygen therapy - The population-based DISCOVERY study. Respir Med. 2023;216:107306. https://doi.org/10.1016/j.rmed.2023.107306.; Garcia-Aymerich J, Monsó E, Marrades RM, Escarrabill J, Félez MA, Sunyer J et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001;164(6):1002–1007. https://doi.org/10.1164/ajrccm.164.6.2006012.; Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur Respir J. 2002;20(1):38–42. https://doi.org/10.1183/09031936.02.00284202.; Górecka D, Gorzelak K, Sliwiński P, Tobiasz M, Zieliński J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax. 1997;52(8):674–679. https://doi.org/10.1136/thx.52.8.674.; Daher A, Dreher M. Supplemental oxygen therapy in chronic obstructive pulmonary disease: is less is more? How much is too much? Curr Opin Pulm Med. 2024;30(2):179–184. https://doi.org/10.1097/mcp.0000000000001025.; Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003;168(9):1034–1042. https://doi.org/10.1164/rccm.200212-1525oc.; Neunhäuserer D, Steidle-Kloc E, Weiss G, Kaiser B, Niederseer D, Hartl S et al. Supplemental Oxygen During High-Intensity Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease. Am J Med. 2016;129(11):1185–1193. https://doi.org/10.1016/j.amjmed.2016.06.023.; Magnussen H, Kirsten AM, Köhler D, Morr H, Sitter H, Worth H et al. Guidelines for long-term oxygen therapy. German Society for Pneumology and Respiratory Medicine. Pneumologie. 2008;62(12):748–756. https://doi.org/10.1055/s-2008-1038290.; Calverley PM, Brezinova V, Douglas NJ, Catterall JR, Flenley DC. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis. 1982;126(2):206–210. https://doi.org/10.1164/arrd.1982.126.2.206.; Tirlapur VG, Mir MA. Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N Engl J Med. 1982;306(3):125–130. https://doi.org/10.1056/nejm198201213060301.; Fletcher EC, Donner CF, Midgren B, Zielinski J, Levi-Valensi P, Braghiroli A et al. Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest. 1992;101(3):649–655. https://doi.org/10.1378/chest.101.3.649.; Fletcher EC, Luckett RA, Goodnight-White S, Miller CC, Qian W, Costarangos-Galarza C. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1992;145(5):1070–1076. https://doi.org/10.1164/ajrccm/145.5.1070.; Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999;14(5):1002–1008. https://doi.org/10.1183/09031936.99.14510029.; O’Donohue WJ Jr. Home oxygen therapy. Clin Chest Med. 1997;18(3):535–545. https://doi.org/10.1016/s0272-5231(05)70400-7.; Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Jaíme A et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest. 2008;134(4):746–752. https://doi.org/10.1378/chest.08-0520.; Alvisi V, Mirkovic T, Nesme P, Guérin C, Milic-Emili J. Acute effects of hyperoxia on dyspnea in hypoxemia patients with chronic airway obstruction at rest. Chest. 2003;123(4):1038–1046. https://doi.org/10.1378/chest.123.4.1038.; Sami R, Savari MA, Mansourian M, Ghazavi R, Meamar R. Effect of Long-Term Oxygen Therapy on Reducing Rehospitalization of Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Pulm Ther. 2023;9(2):255–270. https://doi.org/10.1007/s41030-023-00221-3.; Chow R, So OW, Im JHB, Chapman KR, Orchanian-Cheff A, Gershon AS, Wu R. Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A Systematic Review. Int J Chron Obstruct Pulmon Dis. 2023;18:2581–2617. https://doi.org/10.2147/copd.s418295.; Ekström M, Andersson A, Papadopoulos S, Kipper T, Pedersen B, Kricka O et al. Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia. N Engl J Med. 2024;391(11):977–988. https://doi.org/10.1056/nejmoa2402638.; McDonald CF, Whyte K, Jenkins S, Serginson J, Frith P. Clinical Practice Guideline on Adult Domiciliary Oxygen Therapy: Executive summary from the Thoracic Society of Australia and New Zealand. Respirology. 2016;21(1):76–78. https://doi.org/10.1111/resp.12678.; Calverley PM, Leggett RJ, McElderry L, Flenley DC. Cigarette smoking and secondary polycythemia in hypoxic cor pulmonale. Am Rev Respir Dis. 1982;125(5):507–510. https://doi.org/10.1164/arrd.1982.125.5.507.; Centers for Disease Control and Prevention (CDC). Fatal fires associated with smoking during long-term oxygen therapy – Maine, Massachusetts, New Hampshire, and Oklahoma, 2000–2007. MMWR Morb Mortal Wkly Rep. 2008;57(31):852–854. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5731a3.htm.; Robb BW, Hungness ES, Hershko DD, Warden GD, Kagan RJ. Home oxygen therapy: adjunct or risk factor?. J Burn Care Rehabil. 2003;24(6):403–402. https://doi.org/10.1097/01.bcr.0000096275.27946.68.; Chang TT, Lipinski CA, Sherman HF. A hazard of home oxygen therapy. J Burn Care Rehabil. 2001;22(1):71–74. Available at: https://academic.oup.com/jbcr/article-abstract/22/1/71/4636806?redirectedFrom=fulltext.; Lacasse Y, Légaré M, Maltais F. E-cigarette use in patients receiving home oxygen therapy. Can Respir J. 2015;22(2):83–85. https://doi.org/10.1155/2015/215932.

الاتاحة: https://www.med-sovet.pro/jour/article/view/8667
https://doi.org/10.21518/ms2024-477

المؤلفون: O. N. Titova, N. A. Kuzubova, D. B. Sklyarova, V. A. Volchkov, E. V. Volchkova

المصدر: Туберкулез и болезни лёгких, Vol 97, Iss 9, Pp 45-51 (2019)

مصطلحات موضوعية: хроническая обструктивная болезнь легких, длительная кислородотерапия, фракция утолщения диафрагмы, скорость расслабления диафрагмы, скорость сокращения диафрагмы, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://www.tibl-journal.com/jour/article/view/1336; https://doaj.org/toc/2075-1230; https://doaj.org/toc/2542-1506

URL الوصول: https://doaj.org/article/040e8c423d814e04ac6ba3c3e12df604

المؤلفون: O. N. Titova, N. A. Kuzubova, V. A. Volchkov, A. G. Kozyrev, A. Yu. Gichkin, D. B. Skljarova

المصدر: Бюллетень сибирской медицины, Vol 15, Iss 5, Pp 126-133 (2017)

مصطلحات موضوعية: хроническая обструктивная болезнь легких, гипоксемия, длительная кислородотерапия, диафрагма, Medicine

وصف الملف: electronic resource

Relation: https://bulletin.ssmu.ru/jour/article/view/741; https://doaj.org/toc/1682-0363; https://doaj.org/toc/1819-3684

URL الوصول: https://doaj.org/article/e14e1cb9c09b41e4a82d5bc8ffe9df13

المؤلفون: S. N. Avdeev, С. Н. Авдеев

المصدر: PULMONOLOGIYA; Том 25, № 4 (2015); 469-476 ; Пульмонология; Том 25, № 4 (2015); 469-476 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2015-25-4

مصطلحات موضوعية: тиотропия бромид, prognosis, oxygen therapy, non invasive ventilation, lung transplantation, long acting bronchodilators, tiotropium bromide, прогноз, длительная кислородотерапия, неинвазивная вентиляция легких, трансплантация легких, длительно действующие бронходилататоры

وصف الملف: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/606/551; Lopez A.D., Shibuya K., Rao C. et al. Chronic obstructive pulmonary disease: current burden and future projection. Eur. Respir. J. 2006; 27: 397–412.; Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3: e442.; Buist A.S., McBurnie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (the BOLD Study): a population based prevalence study. Lancet. 2007; 370: 741–750.; Жестков А.В., Косарев В.В., Бабанов С.А., Глазитов А.В. Эпидемиология и факторы риска хронической обструктивной болезни легких в крупном промышленном центре Среднего Поволжья. Профилактика заболеваний и укрепление здоровья. 2009; 1: 42–44. / Zhestkov A.V., Kosarev V.V., Babanov S.A., Glazitov A.V. Epidemiology and risk factors of chronic obstructive pulmonary disease in a large industrial center of the Middle Volga region. Profilaktika zabolevaniy i ukreplenie zdorov'ya. 2009; 1: 42–44 (in Russian).; Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Intern. J. COPD. 2014; 9: 963–974.; Global Initiative for Chronic Obstructive Lung Diseas (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. The 2015 report is available on www.goldcopd.com; Hoyert D.L., Xu J. Deaths: preliminary data for 2011. Natl. Vital. Stat. Rep. 2012; 61: 1–51.; Mannino D.M., Homa D.M., Akinbami L.J. et al. Chronic Obstructive Pulmonary Disease Surveillance – United States, 1971–2000. MMWR Surveillance Summaries. 2002; 51 (SS06): 1–16.; Burney P.G.J., Patel J., Newson R. et al. Global and region al trends in COPD mortality, 1990–2010. Eur. Respir. J. 2015; 45: 1239–1247.; Garcia I.S., Clarа P.C. Causes of death and prediction of mortality in COPD. Arch. Bronconeumol. 2010; 46: 343–346.; Fuso L., Incalzi R.A., Pistelli R. et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am. J. Med. 1995; 98: 272–277.; Vestbo J., Prescott E., Lange P. et al. Vital prognosis after hospitalization for COPD: a study of a random population sample. Respir. Med. 1998; 92: 772–776.; Hansen E.F., Phanareth K., Laursen L.C. et al. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 1267–1271.; Martinez F.J., Foster G., Curtis J.L. et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am. J. Respir. Crit. Care Med. 2006; 173: 1326–1334.; Ries A.L., Kaplan R.M., Limberg T.M., Prewitt L.M. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann. Intern. Med. 1995; 122: 823–832.; Anthonisen N.R., Wright E.C., Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis.1986; 133: 14–20.; Tantucci C., Donati P., Nicosia F. et al. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir. Med. 2008; 102: 613–619.; Casanova C., Cote C., de Torres J.P. et al. Inspiratory to total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 171: 591–597.; Boushy S.F., Coates E.D., Prognostic valie of pulmonary function tests in emphysema: with special reference to arterial blood studies. Am. Rev. Respir. Dis. 1964; 90: 553–563.; Kanner R.E., Renzetti A.D., Stanish W.M. et al. Predictors of survival in subjects with chronic airflow limitation. Am. J. Med. 1983; 74: 249–255.; Nizet T.A.C., van den Elshout F.J.J., Heijdra Y.F. et al. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest. 2005; 127: 1904–1910.; Cooper C.B., Waterhouse J., Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987; 42: 105–110.; Ahmadi Z., Bornefalk Hermansson A., Franklin K.A. et al. Hypo and hypercapnia predict mortality in oxygen dependent chronic obstructive pulmonary disease: a population based prospective study. Respir. Res. 2014, 15: 30.; Burrows B., Kettel L.J., Niden A.H., Rabinowitz M., Diener C.F. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N. Engl. J. Med. 1972; 286: 912–918.; Weitzenblum E., Hirth C., Ducolone A. et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981; 36: 752–758.; Chaouat A., Bugnet A.S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.; Schols A.M., Slangen J., Volovics L.,Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 1791–1797.; Landbo C., Prescott E., Lange P., Vestbo J., Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 1856–1861.; Oga T., Nishimura K., Tsukino M., Sato S., Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am. J. Respir. Crit. Care Med. 2003; 167: 544–549.; Soler Cataluna J.J., Martinez Garcia M.A., Roman S.P. et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005; 60: 925–931.; Suissa S., Dell'aniello S., Ernst P. Long term natural history of chronic obstructive pulmonary disease: severe exacer bations and mortality. Thorax. 2012; 67: 957–963.; Divo M., Cote C., de Torres J.P. et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 186:155–161.; Engstrom G., Lind P., Hedblad B. et al. Lung function and cardiovascular risk: relationship with inflammation sensitive plasma proteins. Circulation. 2002; 106: 2555–2560.; Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? Circulation. 2003; 107: 1514–1519.; Rossi A., Aisanov Z., Avdeev S. et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir. Med. 2015; 109: 785–802.; Zielinski J., MacNee W., Wedzicha J. et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch. Chest Dis. 1997; 52: 43–47.; Seneff M.G., Wagner D.P., Wagner R.P. et al. Hospital and 1 year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995; 274: 1852–1857.; Almagro P., Calbo E., Ochoa de Echaguen A. et al. Mortality after hospitalization for COPD. Chest. 2002; 121: 1441–1448.; Connors A.F., Dawson N.V., Thomas C. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am. J. Respir. Crit. Care Med. 1996; 154: 959–967.; Wouters E.F. The burden of COPD in The Netherlands: results from the confronting COPD survey. Respir. Med. 2003; 97 (Suppl. C): S51–59.; Gunen H., Hacievliyagil S.S., Kosar F. et al. Factors affecting survival of hospitalised patients with COPD. Eur. Respir. J. 2005; 26: 234–241.; Kong G.K., Belman M.J., Weingarten S. Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. Chest. 1997; 111: 89–94.; Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981; i: 681–686.; Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann. Intern. Med. 1980; 93: 391–398.; McEvoy R.D., Pierce R.J., Hillman D. et al. Nocturnal non invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009; 64: 561–566.; Kóhnlein T., Windisch W., Kóhler D. et al. Non invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir. Med. 2014; 2: 698–705.; Lahzami S., Bridevaux P.O., Soccal P.M. et al. Survival impact of lung transplantation for COPD. Eur. Respir. J. 2010; 36: 74–80.; Short P.M., Williamson P.A., Elder D.H. et al. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long acting β agonist therapy in COPD. Chest. 2012; 141: 81–86.; Tashkin D.P., Celli B., Senn S. et al. A 4 year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 1543–1554.; Celli B., Decramer M., Leimer I. et al. Cardiovascular safety of tiotropium in patients with COPD. Chest. 2010; 137; 20–30.; Neff A.L., Petty T.A. Long term continuous oxygen therapy in chronic airway obstruction: mortality in relation to corpulmonale, hypoxia and hypercapnia. Ann. Intern. Med. 1970; 72: 621–626.; Elliot M.W. Non invasive ventilation in chronic obstructive pulmonary disease. In: Simonds A.K., ed. Non Invasive Respiratory Support, 3rd ed. London: Hodder Arnold; 2007.; Leger P., Bedicam J.M., Cornette A. et al. Nasal intermittent positive pressure ventilation. Long term follow up in patients with severe chronic respiratory insufficiency. Chest. 1994; 105: 100–105.; Strumpf D.A., Millman R.P., Carlisle C.C. et al. Nocturnal positive pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1991; 144: 1234–1239.; Marin J.M., Soriano J.B., Carrizo S.J. et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am. J. Respir. Crit. Care Med. 2010; 182: 325–331.; Hogg J.C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004; 364: 709–721.; Pauwels R.A., Lofdahl C.G., Laitinen L.A. et al. Long term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 1999; 340: 1948–1953.; Burge P.S., Calverley P.M., Jones P.W. et al. Randomised, double blind, placebo controled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Br. Med. J. 2000; 320: 1297–1303.; Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N. Engl. J. Med. 2000; 343: 1902–1909.; Lofdahl C.G., Postma D.S., Pride N.B. et al. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur. Respir. J. 2007; 29: 1115–1119.; Calverley P.M., Anderson J.A., Celli B. et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775–789.; Yohannes A.M., Connolly M., Hanania N.A. Ten years of tiotropium: clinical impact and patient perspectives. Int. J. Chron. Obstruct. Pulm. Dis. 2013; 8: 117–125.; Gershon A.S., Wang L., To T. et al. Survival with tiotropium compared to long acting beta 2 agonists in chronic obstructive pulmonary disease. J. COPD. 2008; 5: 229–234.; Lipworth B.J., Short P.M. Explaining differential effects of tiotropium on mortality in COPD. Thorax. 2013; 68: 589–590.; Jenkins C.R., Beasley R. Tiotropium Respimat increases the risk of mortality. Thorax. 2013; 68: 5–7.; Wise R.A., Anzueto A., Cotton D. et al. Tiotropium Respimat Inhaler and the risk of death in COPD. N. Engl. J. Med. 2013; 369: 1491–1501.; https://journal.pulmonology.ru/pulm/article/view/606

الاتاحة: https://journal.pulmonology.ru/pulm/article/view/606
https://doi.org/10.18093/0869-0189-2015-25-4-469-476

المصدر: Здравоохранение Российской Федерации.

مصطلحات موضوعية: ДЛИТЕЛЬНАЯ КИСЛОРОДОТЕРАПИЯ, ХРОНИЧЕСКАЯ ОБСТРУКТИВНАЯ БОЛЕЗНЬ ЛЕГКИХ

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2806::b5ced750165c9fd77bb227e5bd2918f6
http://cyberleninka.ru/article_covers/15808286.png